title: HLA-B40-, HLA-Cw3-, and HLA-DR5-associated susceptibility to amiodarone-induced thyroid dysfunction.
authors.forename: M F
authors.initials: MF
authors.lastname: Erdoğan
authors.forename: S
authors.initials: S
authors.lastname: Güleç
authors.forename: E
authors.initials: E
authors.lastname: Tutar
authors.forename: M
authors.initials: M
authors.lastname: Güldal
authors.forename: N
authors.initials: N
authors.lastname: Başkal
authors.forename: G
authors.initials: G
authors.lastname: Erdoğan
mesh_terms: D000638:Amiodarone / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D006680:HLA Antigens; D015235:HLA-B Antigens; D059947:HLA-B40 Antigen; D015236:HLA-C Antigens; D015805:HLA-DR5 Antigen; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced / Q000276:immunology; D013959:Thyroid Diseases / Q000139:chemically induced* / Q000276:immunology*; D013971:Thyrotoxicosis / Q000139:chemically induced / Q000276:immunology
chemical_list: D000889:Anti-Arrhythmia Agents; D006680:HLA Antigens; D015235:HLA-B Antigens; D059947:HLA-B40 Antigen; D015236:HLA-C Antigens; C038653:HLA-C*03 antigen; D015805:HLA-DR5 Antigen; D000638:Amiodarone